We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.86%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$49.2B
AUM Growth
-$3.11B
Cap. Flow
-$91.1M
Cap. Flow %
-0.19%
Top 10 Hldgs %
25.77%
Holding
2,288
New
88
Increased
463
Reduced
591
Closed
79

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Healthcare 15.91%
3 Financials 13.97%
4 Consumer Discretionary 9.85%
5 Industrials 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAGP icon
2126
Plains GP Holdings
PAGP
$5.22B
$50K ﹤0.01%
4,330
TRST
2127
Trustco Bank Corp NY
TRST
$996M
$50K ﹤0.01%
1,580
NGM
2128
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$50K ﹤0.01%
3,260
TAL icon
2129
TAL Education Group
TAL
$5.8B
$47K ﹤0.01%
15,550
-14,650
-49% -$45K
ANGI icon
2130
Angi Inc
ANGI
$251M
$46K ﹤0.01%
820
CD
2131
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$46K ﹤0.01%
7,250
KOD icon
2132
Kodiak Sciences
KOD
$2.54B
$45K ﹤0.01%
5,820
PRAX icon
2133
Praxis Precision Medicines
PRAX
$8.27B
$45K ﹤0.01%
291
POSH
2134
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$45K ﹤0.01%
3,530
ERIE icon
2135
Erie Indemnity
ERIE
$12.7B
$44K ﹤0.01%
250
-2,915
-92% -$524K
NBP
2136
NovaBridge Biosciences American Depositary Shares
NBP
$200M
$44K ﹤0.01%
2,700
HNGR
2137
DELISTED
Hanger Inc.
HNGR
$44K ﹤0.01%
2,400
FMTX
2138
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$43K ﹤0.01%
4,580
TG icon
2139
Tredegar Corp
TG
$266M
$42K ﹤0.01%
3,539
VERU icon
2140
Veru
VERU
$35.2M
$42K ﹤0.01%
862
ATEN icon
2141
A10 Networks
ATEN
$2.25B
$41K ﹤0.01%
+2,930
New +$41.2K
FDMT icon
2142
4D Molecular Therapeutics
FDMT
$505M
$41K ﹤0.01%
2,680
+470
+21% +$7.38K
PASG icon
2143
Passage Bio
PASG
$14.6M
$41K ﹤0.01%
664
ASTR
2144
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$41K ﹤0.01%
701
+141
+25% +$9.31K
CSTL icon
2145
Castle Biosciences
CSTL
$740M
$40K ﹤0.01%
890
KLRS
2146
Kalaris Therapeutics
KLRS
$83.7M
$39K ﹤0.01%
250
PRPL icon
2147
Purple Innovation
PRPL
$34.8M
$38K ﹤0.01%
260
-800
-75% -$158K
UBA
2148
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$38K ﹤0.01%
2,000
DADA
2149
DELISTED
Dada Nexus
DADA
$37K ﹤0.01%
4,100
GNK icon
2150
Genco Shipping & Trading
GNK
$1.09B
$37K ﹤0.01%
1,580

Similar funds

Ensign Peak Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Ensign Peak Advisors held 2,288 positions worth $49.2B, down 5.9% from $52.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q1 2022 filing shows 88 new, 463 increased, 591 reduced and 79 closed positions. Its largest new stake was Constellation Energy: 260,204 shares worth $14.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q1 2022 buy was Constellation Energy: 260,204 shares worth $14.6M.
  • Ensign Peak Advisors added most to iShares Russell 2000 ETF in Q1 2022, an estimated $261M increase.
  • Ensign Peak Advisors's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Ensign Peak Advisors fully exited Athene Holding Ltd. Class A Common Shares in Q1 2022, selling an estimated $64.3M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $49.2B portfolio in Q1 2022.
  • Ensign Peak Advisors opened 88 new positions and closed 79 in Q1 2022.
  • Ensign Peak Advisors's portfolio value fell 5.9% quarter-over-quarter to $49.2B.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.